AtriCure Inc
NASDAQ:ATRC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.86
38.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
AtriCure Inc
Wall Street
Price Targets
ATRC Price Targets Summary
AtriCure Inc
According to Wall Street analysts, the average 1-year price target for
ATRC
is 46.01 USD
with a low forecast of 36.36 USD and a high forecast of 64.05 USD.
ATRC Last Price Targets
AtriCure Inc
The latest public price target was made on Jul 31, 2024 by
Matt O'Brien
from
Piper Sandler
,
who expects
ATRC
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Matt O'Brien
Piper Sandler
|
40
USD
Upside 31% |
4 months ago
Jul 31, 2024
|
AtriCure price target lowered to $40 from $65 at Piper Sandler
TheFly
|
|
Marie Thibault
BTIG
|
53
USD
Upside 74% |
4 months ago
Jul 31, 2024
|
AtriCure Inc. (ATRC) PT Lowered to $53 at BTIG
StreetInsider
|
Rick Wise
Stifel Nicolaus
|
26
USD
Downside 15% |
4 months ago
Jul 31, 2024
|
AtriCure price target lowered to $26 from $30 at Stifel
TheFly
|
|
Marie Thibault
BTIG
|
58
USD
Upside 90% |
7 months ago
May 2, 2024
|
AtriCure Inc. (ATRC) PT Lowered to $58 at BTIG
StreetInsider
|
Mike Matson
Needham
|
40
USD
Upside 31% |
7 months ago
May 2, 2024
|
AtriCure Inc. (ATRC) PT Lowered to $40 at Needham
StreetInsider
|
Suraj Kalia
Oppenheimer
|
32
USD
Upside 5% |
8 months ago
Apr 23, 2024
|
Oppenheimer Upgrades AtriCure Inc. (ATRC) to Outperform
StreetInsider
|
Unknown Analyst
Canaccord Genuity
|
81
USD
Upside 166% |
1 year ago
Feb 6, 2023
|
Canaccord Genuity Maintains Buy on AtriCure, Raises Price Target to $81
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ATRC's stock price target?
Price Target
46.01
USD
According to Wall Street analysts, the average 1-year price target for
ATRC
is 46.01 USD
with a low forecast of 36.36 USD and a high forecast of 64.05 USD.
What is AtriCure Inc's Revenue forecast?
Projected CAGR
16%
For the last 8 years the
compound annual growth rate for
AtriCure Inc's revenue is
15%.
The projected
CAGR
for the next 4 years is
16%.
You don't have any saved screeners yet
